SYMJEPI FDA approval date

The FDA approved SYMJEPI on 15 Jun 2017.

FDA approval date
15 Jun 2017

Drug identity has not yet been verified against registry records

Also recorded as EPINEPHRINE

Included trials

No linked trials for this drug yet. Browse all trials

PDUFA dates and FDA decisions

Date as reportedDrug / companyEventConditionEvidence
2017-06-15DaySYMJEPIFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA207534", "applicant_as_listed_by_fda": "ADAMIS PHARMS CORP", "brand_names": ["SYMJEPI"], "active_ingredients": ["EPINEPHRINE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20170615", "matched_on": "drug record created from this FDA brand name"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026